HMGB1 is a promising therapeutic target for acute liver failure.

about

Dengue fatal cases present virus-specific HMGB1 response in peripheral organs.High-Mobility Group Box-1 and Liver Disease

P2860

Q45324373-D5A11A2F-F368-431C-AAE7-C293B5C8C830 Q58760274-4A785C99-DDD8-4EA6-8418-718EA146528F

P2860

HMGB1 is a promising therapeutic target for acute liver failure.

Item

http://www.wikidata.org/entity/Q39402112

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

HMGB1 is a promising therapeutic target for acute liver failure.

@en

HMGB1 is a promising therapeutic target for acute liver failure.

@nl

type

Item

label

HMGB1 is a promising therapeutic target for acute liver failure.

@en

HMGB1 is a promising therapeutic target for acute liver failure.

@nl

prefLabel

HMGB1 is a promising therapeutic target for acute liver failure.

@en

HMGB1 is a promising therapeutic target for acute liver failure.

@nl

P1476

HMGB1 is a promising therapeutic target for acute liver failure.

@en

P2093

Yoshitsugu Tajima

http://www.w3.org/2001/XMLSchema#string

P2860

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

Circulating microRNAs, potential biomarkers for drug-induced liver injury

Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

P304

673-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17474124.2017.1345625

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

tetsu yamamoto

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28657371

http://www.w3.org/2001/XMLSchema#string

HMGB1 is a promising therapeutic target for acute liver failure.

about

P2860

P2860

HMGB1 is a promising therapeutic target for acute liver failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698